National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$63.25
add to cart

Rights & Permissions

topleft topright

Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary (2005)
Board on Science, Technology, and Economic Policy (STEP)
National Cancer Policy Board (NCPB)

Citation Manager

. "Appendix I Cost-Effectiveness Analyses of Colorectal Cancer Screening: Results from a Pre-conference Modeling Exercise--Michael Pignone, M.D.,." Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
119
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary

SLIDE 2

SLIDE 2 NOTES: The aims of the pre-Workshop modeling exercise, as I see it, were two-fold: The first was to compare the several different cost-effectiveness analyses of colorectal cancer screening. Such a comparison has three motivations: to gain insight into reasons for different results; to determine areas for future research focus; and potentially to learn something about how different screening strategies stack up against one another. The last motivation, however, is less important than the first two.

The second objective is to use insights from this exercise to better inform future modeling and direct future CRC research efforts. The exercise should lead to better understanding of our parameters, better models, and an identification of questions or issues that need to be incorporated into the models.

Page
119
Front Matter (R1-R8)
Workshop Summary (1-30)
References (31-34)
Appendix A Workshop Agenda: Economic Models of Colorectal Cancer Screening in Average-Risk Adults (35-36)
Appendix B Workshop Participants (37-38)
Appendix C Workshop Speaker and Staff Biographies (39-44)
Appendix D Overview of Harvard Model--Karen M. Kuntz, ScD. (45-60)
Appendix E Description of the Laudabaum Colorectal Cancer Screening Model--Uri Ladabaum, M.D., M.S. (61-72)
Appendix F MISCAN-colon: An Overview--Marjolein van Ballegooijen, Iris Vogelaar, Rob Boer, Franka Loeve, Ann Zauber, Gerrit van Oortmar, and Dik Habbema (73-83)
Appendix G The Vanderbilt Colorectal Cancer Model--R.M. Ness, R.W. Klein, R.S. Dittus (84-104)
Appendix H Overview of the Vijan Colorectal Cancer Screening Model--Sandeep Vijan, M.D., M.S. (105-117)
Appendix I Cost-Effectiveness Analyses of Colorectal Cancer Screening: Results from a Pre-conference Modeling Exercise--Michael Pignone, M.D., (118-153)
Appendix J Recent Findings on Test Performance--Brian P. Mulhall, M.D., M.P.H. (154-188)
Appendix K Cost Issues in Cost Effectiveness Modeling of Colorectal Cancer Screening--Martin L. Brown, Ph.D. (189-207)
Appendix L Current Evidence on Compliance --Sally W. Vernon, M.A., Ph.D. (208-219)
Appendix M Recent Trends in Follow-up Surveillance in Medicare Beneficiaries--Todd Anderson, M.S. (220-231)
Appendix N Preliminary Results from CDC (232-240)
Appendix O Colorectal Cancer Surveillance Testing After Polypectomy--Deborah Schrag, M.D., M.P.H. (241-262)
Appendix P Natural History of Colorectal Adenomas and Cancer--T. R. Levin, M.D. (263-284)
Appendix Q CISNET—Cancer Intervention and Surveillance--Eric J. (Rocky) Feuer, Ph.D. (285-300)